Dupont Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-16,447
Closed -$396K – 1373
2019
Q4
$396K Buy
+16,447
New +$375K 0.01% 948
2017
Q4
– Sell
-39,543
Closed -$888K – 995
2017
Q3
$888K Hold
39,543
– – 0.02% 549
2017
Q2
$1.05M Hold
39,543
– – 0.02% 519
2017
Q1
$1.08M Buy
39,543
+9,554
+32% +$244K 0.02% 505
2016
Q4
$739K Buy
29,989
+7,999
+36% +$169K 0.02% 562
2016
Q3
$498K Hold
21,990
– – 0.01% 567
2016
Q2
$416K Sell
21,990
-44,021
-67% -$919K 0.01% 601
2016
Q1
$1.73M Buy
+66,011
New +$1.53M 0.04% 349

Other funds holding TBI

Dupont Capital Management's TBI Position: Q1 2020 in Review

Dupont Capital Management sold out of Trueblue (TBI) in Q1 2020, closing a stake of 16,447 shares — an estimated $396K sold.

Dupont Capital Management first reported a position in TBI in Q1 2016 and held it in 8 quarters. The position peaked at $1.73M in Q1 2016. 157 funds tracked by Wall St. Rank hold TBI as of Q1 2020.

  • Dupont Capital Management reported no remaining Trueblue position as of Q1 2020 after selling out during the quarter.
  • Dupont Capital Management sold 16,447 Trueblue shares in Q1 2020, an estimated $396K.
  • Dupont Capital Management first reported a position in Trueblue in Q1 2016 and held it in 8 quarters.
  • Dupont Capital Management's Trueblue position peaked at $1.73M in Q1 2016.
  • 157 funds tracked by Wall St. Rank held Trueblue as of Q1 2020.

Based on Dupont Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.